|
"gau jp"的相關文件
顯示項目 1-6 / 6 (共1頁)
1
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2022 |
Distinct immunogenetic profiles of chronic lymphocytic leukemia in Asia: A Taiwan Cooperative Oncology Group Registry Study
|
Yao, CY;Agathangelidis, A;Chuang, SS;Tsou, HH;Feng, WL;Liu, TC;Chen, TY;Yu, YB;Yeh, SP;Yao, M;Wang, CC;Lin, J;Hwang, WL;Gau, JP;Chou, WC;Chao, TY;Lin, LI;Tien, HF;Ghia, P;Wu, SJ |
| 中山醫學大學 |
2021 |
Pomalidomide and Dexamethasone Are Effective in Relapsed or Refractory Multiple Myeloma in a Real-Life Setting: A Multicenter Retrospective Study in Taiwan
|
Hung, YC; Gau, JP; Huang, SY; Ko, BS; Teng, CLJ |
| 中山醫學大學 |
2021 |
Redefining Remission Induction Chemotherapy Ineligibility by Early Mortality in De Novo Acute Myeloid Leukemia
|
Li, YC; Shih, YH; Chen, TC; Gau, JP; Su, YC; Chen, MH; Hsu, CY; Liao, CS; Teng, CLJ |
| 國家衛生研究院 |
2009-02 |
Prognostic significance of beta-catenin and topoisomerase II alpha in de novo acute myeloid leukemia
|
Chen, CG;Gau, JP;You, JY;Lee, KD;Yu, AB;Lu, CH;Lin, JT;Lan, C;Lo, WH;Liu, JM;Yang, CF |
| 國家衛生研究院 |
2001-03 |
Intensive postremission chemotherapy in Taiwanese adults with acute myelogenous leukemia
|
Hsu, HC; Gau, JP; Liu, JM; Chau, WK; Ho, CH |
| 國家衛生研究院 |
1999-11 |
Post-remission intensive consolidation with high-dose cytarabine-based chemotherapy and granulocyte colony-stimulatory factor in adults with acute myelogenous leukemia
|
Hsu, HC;Gau, JP;Liu, JM;Chau, WK;Ho, CH |
顯示項目 1-6 / 6 (共1頁)
1
每頁顯示[10|25|50]項目
|
